胰源性糖尿病的临床诊治策略
本文综述胰源性糖尿病的常见病因(胰腺炎、胰腺导管腺癌、囊性纤维化、胰腺切除术、纤维钙化性胰腺病),估计占所有糖尿病病例的1%至9%。外分泌胰腺疾病患者应筛查糖尿病,糖尿病患者也应考虑潜在胰腺疾病,尤其胰腺导管腺癌可以糖尿病为首发表现。囊性纤维化中糖尿病即使轻微也可加重肺病和死亡风险,外分泌胰腺功能不全者胰腺酶替代治疗可能改善血糖控制。
要点
- 外分泌胰腺疾病患者应筛查糖尿病,糖尿病患者应警惕潜在胰腺疾病。
- 胰腺导管腺癌可以糖尿病为首发表现,临床怀疑至关重要。
- 囊性纤维化中糖尿病即使轻微也可加重肺病和死亡风险。
核心结论
- 胰源性糖尿病占所有糖尿病病例的1%至9%,需根据具体胰腺病理采取不同筛查和治疗策略。
研究设计与样本
- 本文为临床综述,总结胰源性糖尿病的病因、筛查、诊断和治疗策略。
主要发现
- 常见病因包括胰腺炎、胰腺导管腺癌、囊性纤维化、胰腺切除术和纤维钙化性胰腺病。
- 糖尿病可为胰腺导管腺癌的首发表现,目前尚无区分性生物标志物。
- 囊性纤维化中即使轻度糖尿病也可加重肺病和死亡风险。
- 许多胰源性糖尿病病例存在外分泌胰腺功能不全,胰腺酶替代治疗可能改善血糖控制。
临床怎么用
- 对胰腺炎、胰腺导管腺癌、囊性纤维化、胰腺切除术或纤维钙化性胰腺病患者筛查糖尿病。
- 对糖尿病患者警惕腹痛、脂肪泻和吸收不良等外分泌胰腺症状。
- 囊性纤维化患者应尽早诊断糖尿病,即使轻度糖尿病也需关注。
- 合并外分泌胰腺功能不全者考虑胰腺酶替代治疗以改善血糖。
局限性
- 最佳筛查和治疗策略仍在演变,且因具体胰腺病理而异。
- 目前尚无区分胰腺导管腺癌相关糖尿病的生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diabetes can occur secondary to a wide array of exocrine pancreas pathologies. Pancreatogenic diabetes is a broad diagnostic term used to encompass these disparate causes of diabetes, which taken together are estimated to account for 1% to 9% of all cases of diabetes. The more common causes of pancreatogenic diabetes include pancreatitis, pancreatic ductal adenocarcinoma, cystic fibrosis, pancreatectomy, and fibrocalculous pancreatic disease. Persons with these exocrine pancreatic conditions should be screened for diabetes. Reciprocally, clinicians should consider the possibility of underlying pancreatic disease in persons with diabetes. Of special concern, diabetes can be the presenting sign of pancreatic ductal adenocarcinoma, for which clinical suspicion remains crucial as there are not yet distinguishing biomarkers. Timely diagnosis of diabetes is especially important in cystic fibrosis, because even mild diabetes can worsen lung disease and mortality risk in this condition. Exocrine pancreatic insufficiency is present in many cases of pancreatogenic diabetes. In these cases, provision of pancreatic enzyme replacement therapy may improve glycemic control. Optimal screening and treatment approaches are evolving, differing depending on the specific pancreatic pathology. Clinicians should be vigilant for exocrine pancreas symptomatology, including abdominal pain, steatorrhea, and malabsorption in their patients with diabetes.
引用
- Ode KL, Imai Y, Norris AW, et al. Approach to the Patient With Pancreatogenic Diabetes. J Clin Endocrinol Metab. 2026. PMID: 41252284. doi:10.1210/clinem/dgaf623
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。